Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1 mg/mL
Buffer
PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
Konservierungsmittel
ProClin
Vorsichtsmaßnahmen
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Haltbarkeit
12 months
Target
VWA1
(Von Willebrand Factor A Domain Containing 1 (VWA1))
Andere Bezeichnung
VWA1
Hintergrund
Von Willebrand factor A domain-containing protein 1VWA1 belongs to the von Willebrand factor (VWF, MIM 613160) A (VWFA) domain superfamily of extracellular matrix proteins and appears to play a role in cartilage structure and function. VWA1 (Von Willebrand Factor A Domain Containing 1) is a Protein Coding gene. Diseases associated with VWA1 include Ceroid Lipofuscinosis, Neuronal, 8, Northern Epilepsy Variant and Acrofacial Dysostosis 1, Nager Type.